Sema4 Nabs New York State Approval for Cancer Somatic Sequencing Tests

GenomeWeb reported on Sema4 securing approval from the New York State Department of Health to conduct its Sema4 Signal™ Whole Exome/Transcriptome Sequencing and PanCancer somatic tests.